Patents Represented by Attorney, Agent or Law Firm Pepper Hamilton LLP
-
Patent number: 8242044Abstract: Aromatic or heteroaromatic nitro compounds are catalytically hydrogenated to the corresponding amines in the presence of a platinum catalyst comprising elemental platinum on a support; the platinum catalyst is modified with a molybdenum compound and a phosphorus compound wherein the phosphorus has an oxidation state of less than +5, e.g. hypophosphorous acid; the catalyst is particularly useful in the hydrogenation of nitro compounds with halogen and/or sulfur-containing substituents.Type: GrantFiled: September 22, 2010Date of Patent: August 14, 2012Assignee: AstraZeneca ABInventors: Wilhelm Quittman, Thomas Peter Belser, Rhony Niklaus Aufdenblatten
-
Patent number: 8236994Abstract: The present invention provides a method for the anaerobic production of 1,3 propanediol, by culturing a Clostridium strain in an appropriate culture medium comprising glycerol as a source of carbon, wherein said Clostridium strain does not produce substantially other products of the glycerol metabolism selected among the group consisting of: butyrate, lactate, butanol and ethanol, and recovering of 1,3-propanediol.Type: GrantFiled: October 31, 2006Date of Patent: August 7, 2012Assignee: Metabolic ExplorerInventor: Philippe Soucaille
-
Patent number: 8236302Abstract: One aspect of the present invention relates to mutants of chondroitinase ABCI. Such chondroitinase ABCI mutants exhibit altered chondroitin lyase activity or increased resistance to inactivation from stressors including exposure to UV light or heat. Methods of using chondroitinase ABCI mutant enzymes are also provided.Type: GrantFiled: June 4, 2010Date of Patent: August 7, 2012Assignee: Acorda Therapeutics, Inc.Inventors: Anthony O. Caggiano, Jennifer Iaci, Andrea Vecchione, Elizabeth Markensohn
-
Patent number: 8236775Abstract: RNA interference using small interfering RNAs which target HIF-1 alpha mRNA inhibit expression of the HIF-1 alpha gene. As HIF-1 alpha is a transcriptional regulator of VEGF, expression of VEGF is also inhibited. Control of VEGF production through siRNA-mediated down-regulation of HIF-1 alpha can be used to inhibit angiogenesis, in particularly in diseases such as diabetic retinopathy, age related macular degeneration and many types of cancer.Type: GrantFiled: December 3, 2009Date of Patent: August 7, 2012Assignee: The Trustees of the University of PennsylvaniaInventors: Samuel Jotham Reich, Enrico Maria Surace, Michael J. Tolentino
-
Patent number: 8232428Abstract: Aspects of the present invention relate to compounds and methods useful in modulating angiogenesis and methods of treating or preventing diseases associated with angiogenesis by administering a polycationic compound. The present invention relates to methods of use and compositions for inhibiting angiogenesis-mediated disorders in mammals including animals and humans. Additionally, this invention relates to the combined use of polycations with other anti-angiogenesis agents for the treatment of different angiogenesis-mediated disorders. Additionally, those polycationic compounds can be used with various anti-inflammatory and cytotoxic agents as well as with radio-therapeutic agents in cancer patients to prevent and treat tumor growth and metastasis.Type: GrantFiled: March 10, 2010Date of Patent: July 31, 2012Assignee: PolyMedix,Inc.Inventors: Shaker Mousa, Dahui Liu
-
Patent number: 8231888Abstract: Disclosed are compounds of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof, wherein A1, A2, A3, A4, A5 and A6 are independently selected from the group consisting of CR3 and N; provided that at most 3 of A1, A2, A3, A4, A5 and A6 is N; B1, B2 and B3 are independently selected from the group consisting of CR2 and N; each R3 is independently H, halogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 haloalkylthio, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, C1-C6 alkylamino, C2-C6 dialkylamino, —CN or —NO2; and R1, R2, R4, R5, W and n are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound or a composition of the invention.Type: GrantFiled: June 9, 2011Date of Patent: July 31, 2012Assignee: E.I. du Pont de Nemours and CompanyInventors: George Philip Lahm, Wesley Lawrence Shoop, Ming Xu
-
Patent number: 8232247Abstract: The present invention relates to Angiopoietin-3 (Ang-3) and Angiopoietin-4 (Ang-4). The present invention also relates to methods of modulating an activity of Ang-3 or Ang-4. The present invention further relates to methods of treating cancer, diabetes, and arthritis.Type: GrantFiled: May 28, 2004Date of Patent: July 31, 2012Assignee: The Trustees of the University of PennsylvaniaInventors: Yin Xu, Qin Yu
-
Patent number: 8233690Abstract: A method of dynamically reconstructing three dimensional (3D) tomographic images from a set of projection images is disclosed. The method includes the steps of loading a set of projection images into a memory device, determining a reconstruction method for the set of projection images, reconstructing a 3D tomographic image from the set of projection images to be displayed to a user; and performing any post reconstruction processing on the 3D tomographic image.Type: GrantFiled: November 26, 2008Date of Patent: July 31, 2012Assignee: Real-Time Tomography, LLCInventors: Susan Ng, Peter A. Ringer
-
Patent number: 8226253Abstract: The invention is directed to a system for concentrating light for solar thermal and solar photovoltaic generating systems. The system includes a plurality of concentrating regions. Each concentrating region includes an input end having a perimeter or width in a lenticular configuration, an output end having a perimeter or width in a lenticular configuration, and a portion located therebetween defined by a reflective boundary. The invention is also directed to a method of manufacturing a light collection system. The method includes forming a film having multiple recesses. Each recess includes an input end, an output end and a reflective boundary. The output end has a smaller perimeter or a width in a lenticular configuration than a perimeter or a width of the input end in the lenticular configuration.Type: GrantFiled: February 27, 2009Date of Patent: July 24, 2012Inventors: Neil D. Lubart, Thomas E. Lash, Timothy J. Wojciechowski
-
Patent number: 8227444Abstract: Disclosed herein are siRNA compositions and methods useful for inhibiting expression of vascular endothelial growth factor (VEGF) isoforms. Diseases which involve angiogenesis stimulated by overexpression of VEGF, such as diabetic retinopathy, age related macular degeneration and many types of cancer, can be treated by administering small interfering RNAs as disclosed.Type: GrantFiled: December 6, 2010Date of Patent: July 24, 2012Assignee: Opko Ophthalmics, LLCInventor: Nadine Dejneka
-
Patent number: 8226941Abstract: An aspect of the present invention relates to stable formulations of chondroitinase and to methods of purifying chondroitinase. The methods of purifying chondroitinase includes the steps of extracting the enzyme from a cell, separating the chondroitinase from the crude cell extract using cation-exchange chromatography, removing impurities through gel filtration chromatography, and removing endotoxin through an anion-exchange membrane to produce a purified chondroitinase.Type: GrantFiled: May 18, 2005Date of Patent: July 24, 2012Assignee: Acorda Therapeutics, Inc.Inventors: Anthony O. Caggiano, Elliott A. Gruskin, Yelena G. Sheptovitsky, Sarah Kasperbauer
-
Patent number: 8222211Abstract: A novel class of embryo derived peptides are described (Preimplantation factor) that were generated synthetically and were tested on peripheral blood immune cells and shown to block activated but not basal immunity, inhibiting cell proliferation and creating a TH2 type cytokine bias. In addition PIF peptides enhance endometrial receptivity by increasing adhesion molecules expression. PIF biological activity appears to be exerted by specific binding to inducible receptors present on the several white cell lineages. PIF peptides, which are immune modulators, therefore may have diagnostic and non toxic therapeutic applications in improving fertility, reducing pregnancy loss as well may be useful when administered for the treatment of autoimmune diseases and for prevention xenotransplants rejection.Type: GrantFiled: October 22, 2004Date of Patent: July 17, 2012Assignee: BioIncept, LLCInventor: Eytan R. Barnea
-
Patent number: 8220611Abstract: A system is disclosed for mounting currency mechanisms of various sizes and shapes in vending machines or the like. The system may allow for relatively simple installation and removal of currency mechanisms without the use of mounting screws. The system includes a mounting surface, a portion of which is adapted to mate with a first surface of a currency mechanism. A tab is extended from the mounting surface to engage an opening in the first surface of the currency mechanism. A retention device is coupled to the mounting surface and is manipulable to engage a second surface of the currency mechanism and to cooperate with the tab to grip the currency mechanism.Type: GrantFiled: June 15, 2005Date of Patent: July 17, 2012Assignee: MEI, Inc.Inventor: Evan J. Cost
-
Patent number: 8221452Abstract: Systems and methods introduce a closure material to seal a vessel puncture site. The system and methods provide a catheter adapted for passage through a tissue puncture and sized to occupy substantially all the tissue puncture. The catheter includes a lumen in fluid communication with a fluid delivery port adjacent the catheter distal end. One or more dispensers are in fluid communication with the catheter lumen for dispensing first and second fluid compositions in the catheter lumen. An actuator causes the first and second fluid compositions to be dispensed from the dispensers and mixed by flowing the first and second fluid compositions through a static mixer. The first and second fluid compositions are dispensed from the fluid delivery port as a fluid mixture that reacts in situ to form a nonfluent closure composition adjacent the vessel puncture site.Type: GrantFiled: February 13, 2008Date of Patent: July 17, 2012Assignee: Neomend, Inc.Inventors: Stuart D. Edwards, Ronald Lax, Theodore L. Parker, Thomas C. Wehman, Theodore Kucklick, Eugene Skalnyi
-
Patent number: 8221736Abstract: cis-Jasmone has been discovered to be useful as a semiochemical that changes the behavior of insects and/or the physiology of plants. It has direct signalling roles with plant-feeding aphids, in attraction of aphid predators and parasitoids, and may act as an airborne signal inducing production of volatile plant semiochemicals, including the monoterpene (E)-?-ocimene, that stimulate foraging by parasitoids. It is an extremely benign compound having, to human beings, a pleasant aroma and gives a long-lasting effect after removal of the stimulus.Type: GrantFiled: May 18, 2010Date of Patent: July 17, 2012Assignee: Rothamsted Research LimitedInventors: Alastair James Hick, John Anthony Pickett, Lester John Wadhams, Johnathan Andrew Napier
-
Patent number: 8221711Abstract: Compositions and methods for removing mercury and/or cadmium from samples containing mercury and/or cadmium or thought to contain mercury and/or cadmium are described. Selenium core-sheath compositions containing a selenium nanostructure core and a melt-resistant sheath can be used to remove mercury and/or cadmium from high-temperature environments.Type: GrantFiled: September 13, 2011Date of Patent: July 17, 2012Assignee: Empire Technology Development LLCInventor: Kwangyeol Lee
-
Patent number: 8217180Abstract: Disclosed is a method for preparing a compound of Formula 1 wherein R1 is CHX2, CX3, CX2CHX2 or CX2CX3; each X is independently Cl or F; Z is optionally substituted phenyl; and Q is phenyl or 1-naphthalenyl, each optionally substituted as defined in the disclosure; comprising contacting a compound of Formula 2 with hydroxylamine in the presence of a base. The present invention also relates to novel compounds of Formula 2, useful as starting materials for the aforedescribed method.Type: GrantFiled: August 4, 2008Date of Patent: July 10, 2012Assignee: E.I. du Pont de Nemours and CompanyInventors: Gary David Annis, Brenton Todd Smith
-
Patent number: 8216535Abstract: Methods and systems for reducing mercury emissions from fluid streams having a high concentration of sulfur oxide species are provided herein. In embodiments, mercury is removed from flue gas streams containing sulfur trioxide (SO3) by injecting a dry admixture of a porous mercury adsorptive material and at least one dry agent into the flue gas stream.Type: GrantFiled: September 28, 2010Date of Patent: July 10, 2012Assignee: Calgon Carbon CorporationInventors: Nicholas R. Pollack, Richard A. Hayden
-
Patent number: 8216585Abstract: Drug delivery compositions and methods of delivering compounds into a cell or into an individual are disclosed. Vaccines and methods of immunizing individuals are disclosed. Compositions for drug delivery including gene therapy and methods of treating individuals using such compositions are disclosed.Type: GrantFiled: May 28, 2002Date of Patent: July 10, 2012Assignee: The Trustees of the University of PennsylvaniaInventors: David B. Weiner, Karuppiah Muthumani, Donghui Zhang, Mathura P. Ramanathan
-
Patent number: 8210435Abstract: An apparatus for marking predetermined known overhead positional locations within a coordinate space, for viewing by an image acquisition system. The apparatus comprises a plurality of marker tags, grouped in one or more rows, each row having an axis, each row being supported by a row support. Each marker tag comprises an optically opaque, dark colored corrugated substrate, substantially rectangular in shape. A label having a unique machine-readable barcode symbology printed thereon is positioned centrally on the substrate so that a dark colored border of the substrate surrounds the label. Each row support comprises a first support cord and a second support cord. The first support cord supports a first lateral edge of the marker tags in a row group in a fixed, spaced-apart positional arrangement. The second support cord supports the second lateral edge of the marker tags in the row in a slidable support arrangement.Type: GrantFiled: January 13, 2009Date of Patent: July 3, 2012Assignee: Sky-Trax, Inc.Inventors: Larry G. Mahan, Sarah M. Brisbin, Kimberly M. Martine